"Located on the Torrey Pines Mesa in San Diego, the Scripps MD Anderson Cancer Center serves Scripps patients from across the region who require radiation therapies. Patients who are referred from any of Scripps 23 outpatient centers and five hospital campuses may receive leading-edge radiation treatment in this compassionate, comfortable, modern setting. Free Wi-Fi is available."

During the past decade, Scripps Cancer Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 16 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scripps Cancer Center" #1 sponsor was "NSABP Foundation Inc" with 7 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Celgene Corporation" with 2 trials sponsored, "Genzyme, a Sanofi Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scripps Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Scripps Cancer Center" are "Breast Cancer" (8 trials), "Acute Myeloid Leukemia" (5 trials), "Leukemia" (3 trials), "Melanoma" (3 trials) and "Pancreatic Cancer" (3 trials). Many other conditions were trialed in "Scripps Cancer Center" in a lesser frequency.

Most popular intervention types in "Scripps Cancer Center" are "Drug" (43 trials), "Biological" (9 trials), "Other" (4 trials), "Procedure" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Gemcitabine" (4 trials), "cyclophosphamide" (4 trials), "fluorouracil" (3 trials) and "paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Scripps Cancer Center" are 39 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "Scripps Cancer Center". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Scripps Cancer Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Scripps Cancer Center, 6 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".